Maintenance Regimens for Multiple Myeloma

Maintenance Regimens for Multiple Myeloma

obr

6 months
27 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Robert Rifkin, MD, McKesson Biosimilars, Associate Chair, Rocky Mountain Cancer Centers explains maintenance regimens for multiple myeloma (MM) patients.
Up Next Autoplay
TOURMALINE-MM4: What's Next in Research?
TOURMALINE-MM4: What's Next in Research?
Category: Multiple Myeloma
0 Views
Cancer-News 1 day
TOURMALINE-MM4: Are There Safety Concerns?
TOURMALINE-MM4: Are There Safety Concerns?
Category: Multiple Myeloma
0 Views
Cancer-News 1 day
TOURMALINE-MM4: Regulatory Pathway
TOURMALINE-MM4: Regulatory Pathway
Category: Multiple Myeloma
0 Views
Cancer-News 1 day
Why was NINLARO compared to a placebo in TOURMALINE-MM4?
Why was NINLARO compared to a placebo in TOURMALINE-MM4?
Category: Multiple Myeloma
0 Views
Cancer-News 1 day
TOURMALINE-MM4 Study
TOURMALINE-MM4 Study
Category: Multiple Myeloma
0 Views
Cancer-News 1 day
Phase 3 Trial of NINLARO (ixazomib) as First Line Maintenance Therapy
Phase 3 Trial of NINLARO (ixazomib) as First Line Maintenance Therapy
Category: Multiple Myeloma
1 Views
Cancer-News 1 day
Multiple Myeloma Disparities #ASH19 @WinshipAtEmory
Multiple Myeloma Disparities #ASH19 @WinshipAtEmory
Category: Multiple Myeloma
31 Views
ash 1 month
GRIFFIN Study Update #ASH19 @LevineCancer
GRIFFIN Study Update #ASH19 @LevineCancer
Category: Multiple Myeloma
3 Views
ash 1 month
Phase 1 Clinical Study (CRB-402) of bb21217 #ASH19 @BerdejaJesus
Phase 1 Clinical Study (CRB-402) of bb21217 #ASH19 @BerdejaJesus
Category: Multiple Myeloma
16 Views
ash 1 month
ICARIA-MM: What's Next? #ASH19
ICARIA-MM: What's Next? #ASH19
Category: Multiple Myeloma
6 Views
ash 1 month